(AMGN) Amgen trading up another 2% after vote from FDA was not to put additional caps on company.
(BRLC) Syntax-Brillian rescheduled earnings from yesterday’s close to today’s close.
(CATT) Catapult Communications said its order input for the quarter have so far exceeded original expectations.
(CRZO) Carrizo Oil & Gas sold 1.8 million shares in a direct placement.
(CTIC) Cell Therapeutics is launching Phase III study for pixantrone in relapsed non-Hodgkin’s lymphoma.
(DCO) Ducommun won $28 million in contracts from Embraer for fuselage and door skins.
(ENP) Encore Energy Partners LP priced its IPO of 9.0 million units at $21.00 per unit.
(FRZ) Reddy Ice announced the sale of most of its non-ice assets.
(GM) GMAC LLC, GM’s partly owned finance unit, signed a $21.4 Billion asset-backed credit loan facility from Citigroup.
(GOAM) GoAmerica is merging with Hands On Video Relay Services.
(ILMN) Illumina signed its fourth genotyping service agreement with Cancer Research Center in the U.K.
(IW) ImageWare signed a fingerprint ID system pact with Lockheed Martin.
(JOSB) Jos. A. Banks $0.44 EPS vs $0.42 est.
(KWK) Quicksilver Resources is selling its Michigan, Indiana, and Kentucky assets.
(NDAQ) NASDAQ is reportedly not increasing its bid for OMX.
(OHB) Orleans Homebuilders -$0.03 EPS vs -$0.20 est.
(PCOP) Pharmacopeia announced positive results from Phase 1 multiple ascending dose study of PS433540, its lead product candidate.
(RPRX) Repros Therapeutics announces that its investigational new drug application in the treatment of Endometriosis became effective.
(TXN) Texas Instruments traded down 1% after narrowing the range within prior expectations; wireless chips were seeing mixed demand.
Jon C. Ogg
September 12, 2007